Multimodality neuromonitoring for neurocardiology

Journal of Interventional Cardiology

Volumn 11, Issue 3, 1998, Pages 197-204

  Edmonds Jr , Harvey L ^a   Singer, Igor ^a   Sehic, Aida ^a   Strickland, Ted J ^a  

^a UNIVERSITY OF LOUISVILLE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BLOOD FLOW VELOCITY; BRAIN BLOOD FLOW; DEFIBRILLATION; DIAGNOSTIC VALUE; DOPPLER ECHOGRAPHY; HEART INNERVATION; HEART RATE; HUMAN; HUMAN TISSUE; HYPOTENSION; INFRARED SPECTROSCOPY; PACEMAKER; PRIORITY JOURNAL; QUANTITATIVE DIAGNOSIS; SEIZURE; SYNCOPE;

EID: 7144256531     PISSN: 08964327     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1540-8183.1998.tb00119.x     Document Type: Article

References (32)

1. Johnson R, Lambie D, Spalding J. Neurocardiology: The Interrelationships Between Dysfunction in the Nervous and Cardiovascular Systems. Philadelphia, PA, WB Saunders, 1984, pp. 1-14.
2. Kapoor WN, Smith MA, Miller NL. Upright tilt testing in evaluating syncope: A comprehensive literature review. Am J Med 1994;97:78-88.
3. Daffertshofer M, Hennerici M. Cerebrovascular regulation and vasoneuronal coupling. J Clin Ultrasound 1995;23: 125-138.
4. Larsen FS, Olsen KS, Hansen BA, et al. Transcranial Doppler is valid for determination of the lower limit of cerebral blood flow autoregulation. Stroke 1994;25:1985-1988.
5. Singer I, Edmonds HL Jr. Cerebrovasomotor reactivity predicts tolerance to tiered therapy with implantable cardioverter-defibrillators. In: Aubert AE, Ector H, Stroobandt R, eds. Cardiac Pacing and Electrophysiology: A Bridge to the 21st Century. Dordrecht, the Netherlands: Kluwer Academic Publishers, 1994, pp. 387-397.
6. Singer I, van der Laken J, Edmonds HL Jr, et al. Is defibrillation testing safe? PACE 1991;14:1899-1904.
7. Heil T, Spies C, Rieger A, et al. Prolonged EEG depression by repetitive defibrillation testing in ICD implantation. (Abstract) Anesthesiology 1992;77:A 161.
8. Murkin JM, Baird DL, Martzke JS, et al. Cognitive dysfunction after ventricular fibrillation during implantable cardioverter-defibrillator procedures is related to duration of the reperfusion interval. Anesth Analg 1997;84:1186-1192.
9. Aminoff MJ, Scheinman MM, Griffn JC, et al. Electrocerebral accompaniments of syncope associated with malignant ventricular arrthythmia. Ann Intern Med 1988;108:791-796.
10. Clute HL, Levy WJ. Electroencephalographic changes during brief cardiac arrest in humans. Anesthesiology 1990;73:821-825.
11. Konstandt SN, Black S, Seigil L, et al. The effects of global normothermic hypoperfusion on the processed electroencephalogram in patients. J Cardiothorac Vasc Anesth 1991;5:214-217.
12. Singer I, Edmonds HL Jr. Changes in cerebral perfusion during third-generation implantable cardioverter-defibrillator testing. Am Heart J 1994;127:1052-1057.
13. McCormick PW, Stewart M, Goetting MG, et al. Regional cerebrovascular oxygen saturation measured by optical spectroscopy in humans. Stroke 1991;22:596-601.
14. Wyatt JS, Cope M, Delpy DT, et al. Quantitalion of cerebral blood volume in human infants by near-infrared spectroscopy. J Appl Physiol 1990;68:1086-1091.
15. Avramov MN, White PF. Methods for monitoring the level of sedation. Crit Care Clin 1995;11:803-826.
16. Rosow C, Manberg PJ. Bispectral index monitoring. Anesth Clin North Am 1998;2:89-107.
17. Grubb BP, Gerard G, Roush K, et al. Cerebral vasoconstriction during head upright tilt induced vasovagal syncope: A paradoxic and unexpected response. Circulation 1991;84:1157-1164.
18. Lam AM. Change in cerebral blood flow velocity pattern during induced hypotension: A noninvasive indicator of increased intracranial pressure? Br J Anaesth 1992;68:424-428.
19. Mattle HP, Nirkko AC, Baumgartner RW, et al. Transient cerebral circulatory arrest coincides with fainting in cough syncope. Neurology 1995;45:498-501.
20. Petersen MEV, Chamberlain-Weber R, Fitzpatrick AP, et al. Permanent pacing for cardioinhibitory malignant vasovagal syndrome. Br Heart J 1994;71:274-281.
21. Bruggemans EF, Van Dijk JG, Huysmans HA. Residual cognitive dysfunctioning at 6 months following coronary artery bypass graft surgery. Eur J Cardiothorac Surg 1995;9:636-643.
22. Clark RE, Brillman J, Davis DA, et al. Microemboli during coronary artery bypass graftting: Genesis and effect on outcome. J Thorac Cardiovasc Surg 1995;109:249-258.
23. Barbut D, Lo Y-W, Gold JP, et al. Impact of embolization during coronary artery bypass grafting on outcome and length of stay. Ann Thorac Surg 1997;63:998-1002.
24. Booke M, Fobker M, Fingerhut D, et al. Fat elimination during intraoperative autotransfusion: An in vitro investigation. Anesth Analg 1997;85:959-962.
25. Roach GW, Kanchuger M, Magano CM, et al. Adverse cerebral outcomes after coronary bypass surgery. N Engl J Med 1996;335:1857-1863.
26. Goldberg ME, Segraves MA. The visual and frontal cortices. In: Wurtz RH, Goldberg ME, eds. The Neurobiology of Saccadic Eye Movements. Amsterdam: Elsevier, 1989, pp. 283-313.
27. Currie J, Ramsden B, McArthur C, et al. Validation of a clinical antisaccadic eye movement test in the assessment of dementia. Arch Neurol 1991;48:644-648.
28. Folstein MF, Molstien SE, McHugh PR. "Mini-Mental State." A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198.
29. Edmonds HL Jr, Rodriguez RA, Audenaert SM, et al. The role of neuromonitoring in cardiovascular surgery. J Cardiothorac Vasc Anesth 1996;10:15-23.
30. Urzua J, Meneses G, Fajardo C, et al. Arterial pressure-flow relationship in patients undergoing cardiopulmonary bypass. Anesth Analg 1997;84:958-963
31. Austin EH III, Edmonds HL Jr, Seremet V, et al. Benefit of neuromonitoring for pediatric cardiac surgery. J Thorac Cardiovasc Surg (in press).
32. Edmonds HL Jr, Toney KA, Thomas MH, et al. Neuromonitoring cost-benefit for adult cardiac surgery. (Abstract) Anesthesiology 1997;87(3A):A426.